Long-term health outcomes in survivors of childhood AML treated with allogeneic HSCT: a NOPHO-AML Study.

Added 1212 days ago (23.09.2018)
Authors: Wilhelmsson M, Glosli H, Ifversen M, Abrahamsson J, Winiarski J, Jahnukainen K, Hasle H, Nordic Society of Pediatric Hematology and Oncology (NOPHO)
PubMed id: 30242226
Read article